Performance of ZLAB Zai Lab | -37.3% in 12m
Compare ZLAB with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Zai Lab with its related Sector/Index XBI
![Compare Zai Lab with its related Sector/Index XBI](https://www.valueray.com/images/chart/ZLAB.NASDAQ_perf.png)
Performance Duell ZLAB vs XBI
TimeFrame | ZLAB | XBI |
---|---|---|
1 Day | -0.05% | 0.55% |
1 Week | 1.07% | 4.13% |
1 Month | 4.95% | 10.14% |
3 Months | 18.5% | 21.77% |
6 Months | -17.1% | 15.22% |
12 Months | -37.3% | 20.63% |
YTD | -27.6% | 12.67% |
Rel. Perf. 1m | -0.50 | |
Rel. Perf. 3m | -0.86 | |
Rel. Perf. 6m | -2.86 | |
Rel. Perf. 12m | -2.86 |
Is Zai Lab a good stock to buy?
No, based on ValueRay Fundamental Analyses, Zai Lab (NASDAQ:ZLAB) is currently (July 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -57.42 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZLAB as of July 2024 is 15.46. This means that ZLAB is currently overvalued and has a potential downside of -18.03% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZLAB as of July 2024 is 15.46. This means that ZLAB is currently overvalued and has a potential downside of -18.03% (Sold with Premium).
Is ZLAB a buy, sell or hold?
- Strong Buy: 6
- Buy: 4
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: ZLAB is performing better - Values below 0%: ZLAB is underperforming
Compare ZLAB with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.90% | 5.15% | -29.47% | -57.85% |
US NASDAQ 100 | QQQ | 3.65% | 8.57% | -26.62% | -58.76% |
US Dow Jones Industrial 30 | DIA | 0.32% | 1.14% | -24.52% | -53.53% |
German DAX 40 | DBXD | -0.32% | 3.51% | -25.16% | -52.12% |
UK FTSE 100 | ISFU | -0.12% | 2.34% | -28.61% | -52.43% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.07% | 5.25% | -19.18% | -21.67% |
Hongkong Hang Seng | HSI | 2.49% | 5.73% | -13.06% | -17.25% |
Japan Nikkei 225 | EXX7 | 2.58% | 6.10% | -18.60% | -48.17% |
India NIFTY 50 | INDA | -0.07% | 2.05% | -32.57% | -64.20% |
Brasil Bovespa | EWZ | 2.00% | 3.56% | -2.93% | -24.86% |
ZLAB Zai Lab vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 2.73% | 7.58% | -25.39% | -60.19% |
Consumer Discretionary | XLY | 3.84% | 5.34% | -23.89% | -43.20% |
Consumer Staples | XLP | 0.56% | 3.34% | -26.75% | -43.94% |
Energy | XLE | 1.26% | 3.18% | -28.25% | -46.17% |
Financial | XLF | -0.24% | -0.88% | -30.24% | -62.25% |
Health Care | XLV | -0.34% | 2.31% | -25.55% | -50.86% |
Industrial | XLI | -0.08% | 1.16% | -29.13% | -53.49% |
Materials | XLB | -0.28% | 1.86% | -28.68% | -45.97% |
Real Estate | XLRE | 0.53% | -2.92% | -24.68% | -47.75% |
Technology | XLK | 3.15% | 9.35% | -24.63% | -59.47% |
Utilities | XLU | -0.41% | 1.49% | -35.24% | -47.01% |
Aerospace & Defense | XAR | -2.57% | -0.74% | -32.14% | -56.99% |
Biotech | XBI | -3.06% | -5.19% | -32.28% | -57.89% |
Homebuilder | XHB | -3.22% | -11.05% | -40.87% | -76.60% |
Retail | XRT | -1.02% | 2.32% | -28.17% | -52.75% |
Does Zai Lab outperform its market, is ZLAB a Sector Leader?
No, over the last 12 months Zai Lab (ZLAB) made -37.26%, while its related Sector, the SPDR S&P Biotech (XBI) made 20.63%.
Over the last 3 months ZLAB made 18.54%, while XBI made 21.77%.
No, over the last 12 months Zai Lab (ZLAB) made -37.26%, while its related Sector, the SPDR S&P Biotech (XBI) made 20.63%.
Over the last 3 months ZLAB made 18.54%, while XBI made 21.77%.
Period | ZLAB | XBI | S&P 500 |
---|---|---|---|
1 Month | 4.95% | 10.14% | -0.20% |
3 Months | 18.54% | 21.77% | 7.46% |
12 Months | -37.26% | 20.63% | 20.59% |